Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 24,741 | 24,615 | 24,754 | 29,992 | 26,303 |
| Cost of Goods | 10,955 | 10,841 | 12,322 | 14,801 | 12,177 |
| Gross Profit | 13,786 | 13,774 | 12,432 | 15,191 | 14,126 |
| Operating Expenses | 12,133 | 12,924 | 12,722 | 11,410 | 10,026 |
| Operating Income | 1,653 | 850 | -290 | 3,781 | 4,100 |
| Interest Expense | 1,407 | 1,406 | 2,005 | 1,996 | 2,163 |
| Other Income | -573 | 1,171 | 1,536 | -905 | -2,518 |
| Pre-tax Income | -327 | 615 | -759 | 880 | -581 |
| Income Tax | -12 | 99 | -206 | 147 | -691 |
| Net Income Continuous | -315 | 516 | -553 | 733 | 110 |
| Net Income | $-315 | $516 | $-553 | $733 | $110 |
| EPS Basic Total Ops | -0.01 | 0.02 | -0.02 | 0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.02 | -0.02 | 0.03 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.02 | -0.03 | 0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.02 | -0.03 | 0.03 | 0.00 |
| EBITDA(a) | $3,508 | $4,447 | $3,682 | $4,632 | $3,158 |